Tencent and existing investor Nan Fung Life Sciences have helped the ophthalmology drug developer complete its series B round.

Cybrexa has secured $25m to progress a cancer treatment based on research at Yale University and University of Rhode Island.

The commercialisation firm will pay its maiden dividend after achieving net portfolio gains of 22% and a 140% increase in cash realisations.

Krafton has invested $22.5m in the esports event promoter, which counts Nazara as its majority shareholder.

Soravia has backed the short-term apartment provider in a $23.8m round that came 19 months after its $6m seed round.

The nanoemulsion delivery system developer raised series A funding from Haohai Biological alongside an $8m payment for the Chinese rights to its products.

The revenue trading platform developer secured $50m in a round co-led by Siemens Next47 and backed by Shopify, Okta, HubSpot and Slack.

Rabo Frontier Ventures and existing backer AgFunder contributed to a series A-plus round taking the farming networking platform developer's overall funding to $32m.

Existing investor Deppon Express was among the participants in a round for the robotic forklift developer sized at roughly $15m.

Dell Technologies Capital returned for a round that took the cancer diagnostics technology developer's overall funding to $52m.